Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EFFET pilot study of folinic acid in children with autism spectrum disorder
2015-000955-25Phase 2
- Sponsor
- CHRU Nancy
- Start
- Jun 2015
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial in Autism Spectrum Disorder (ASD) comparing Folinic acid with Placebo (2 arms). Primary endpoint: Change in ADOS communication and social interaction scores.
02
Drugs
folinic acid
03
Conditions
Autism Spectrum Disorder (ASD)
Beyond the preview
Go deeper on 2015-000955-25.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-000955-25.